Last edition
News about "Lamotrigine Extended-Release Tablets "
Alembic Pharma Gets FDA Approval for Lamotrigine Extended-Release Tablets
The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Lamictal XR Extended-Release Tablets, 200 mg, 250 mg, and 300 mg, of GlaxoSmithKline LLC (GSK).
Lamotrigine Extended-Release Tablets | 07/10/2024 | By Aishwarya | 102
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members